Intarcia Therapeutics, Inc. Alternatives & Competitors

12 companies similar to Intarcia Therapeutics, Inc.

Symic Bio

A new category of therapeutics based on extracellular matrix biology

2 Series C $84.15M

San Francisco, United Sta...

Biotechnology Health Care

EnteroBiotix

Mastering the microbiome, transforming lives®

55 Venture round $64.00M

Biotechnology Health Care +1

Yaqrit

The Liver Disease Company

14 Convertible Note $15.70M

London, United Kingdom

Biotechnology Health Care +3

Kernal Biologics

KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...

22 Series A $26.82M

Cambridge, United States

Biotechnology Health and Wellness +1

Track all Intarcia Therapeutics, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

THRASOS LIMITED

Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on k...

2 Series D $56.00M

Biotechnology Health Care +2

Pinteon Therapeutics

Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...

2-10 Series B $51.60M

Biotechnology Health Care +1

Sidansai

A Shanghai-based biotechnology company pioneering the advancement of cell therapy.

2 Series C $28.60M

Biotechnology Health Care +2

Aurion Biotech

We're on a mission to cure blindness with our transformational platform of advanced therap...

94 Acquired $120.00M

Seattle, United States

Biopharma Biotechnology +1

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

ABIONYX Pharma

A New Generation Biotech Company

8 Grant $140.00M

Balma, France

Biotechnology Health Care

FimmCyte

First disease modifying treatment for Endometriosis.

7 Seed $1.30M

Basel, Switzerland

Biotechnology Health Care

Carrick Therapeutics

Transformative Cancer Medicines

16 Series C $155.00M

Dublin, Ireland

Biotechnology Health Care +2

About Intarcia Therapeutics, Inc.

Intarcia Therapeutics, Inc. is a rapidly emerging biotech company driven by a "No Analog" mindset, dedicated to redesigning the treatment, prevention, and experience of chronic diseases. Founded in 1997, the company operates in the Biotechnology and Health Care industries, with its headquarters in the United States.

Taxonomy

Biotech, Medical Innovation, Chronic Disease Treatment, Biopharmaceuticals, Health Impact, Innovative Therapies, Cross-disciplinary Collaboration, Medical Research, Future Of Medicine

Frequently Asked Questions

Companies similar to Intarcia Therapeutics, Inc. include Symic Bio, EnteroBiotix, Yaqrit, Kernal Biologics, THRASOS LIMITED. They work in Biotechnology and Health Care and share Intarcia Therapeutics, Inc.'s focus on biopharmaceuticals, medical research and innovative therapies.

Bounce Watch lists 12 companies that share Intarcia Therapeutics, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Intarcia Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Intarcia Therapeutics, Inc. Profile Symic Bio Alternatives EnteroBiotix Alternatives Yaqrit Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Intarcia Therapeutics, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.